China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a report released on Sunday. The firm issued a hold rating on the stock.

China Pharma Price Performance

Shares of NYSE:CPHI opened at $0.20 on Friday. China Pharma has a 1 year low of $0.13 and a 1 year high of $0.60. The firm has a fifty day moving average price of $0.21 and a 200 day moving average price of $0.21. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.